drugset / Trial / NCT04152317
Dose Comparison of Misoprostol for Cervix Ripening Before Operative Hysteroscopy.
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The medication misoprostol is used to facilitate the entry into the uterus of hysteroscopy surgery equipment and this research aims to compare the results of the use of this drug in two different doses trying to find the optimal one. To perform this work we will use the misoprostol and will perform a questionnaire that will be asked during hospitalization, before, during and the 12hours after the surgery. The patients who meet the inclusion criteria after signing the Informed Consent Form will be allocated into two groups getting misoprostol 200mcg or misoprostol 800mcg.
Timeline
- Start
- 2019-11-07
- Primary completion
- 2020-09-11
- Completion
- 2020-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 200 ug | Intravenous |
| Subject | Misoprostol | Other / unclassified | 800 ug | Intravenous |